Vikas Gupta, MD, PhD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (123 ratings)

Role

Hematology Oncology
Specialty

Myeloma and Plasma Cell Disorders
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2015

Request Appointment

Background

Vikas A. Gupta, MD, PhD, is an Instructor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He joined the clinical staff at Winship Cancer Institute as a practicing physician in September 2015.

Dr. Gupta earned his PhD in Biomedical Sciences and his MD from the University of California, San Francisco. After obtaining his MD, Dr. Gupta completed both his residency in Internal Medicine and his post-doctoral fellowship in Hematology/Oncology at Emory University where he was named Chief Fellow.

Titles & Roles

Assistant Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Medical Oncology/Hematology, 2015
Emory University School of Medicine
Residency, Internal Medicine, 2011
Emory University School of Medicine
Medical Education, , 2009
University of California San Francisco

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2015
Hematology
American Board of Internal Medicine, 2015
Internal Medicine
American Board of Internal Medicine, 2013

Title/Journal	Authors	Publication Date
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal	SA Scott, EM Marin, KT Maples, NS Joseph, CC Hofmeister, VA Gupta, MV Dhodapkar, JL Kaufman, S Lonial, AK Nooka	20/12/2023
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer research communications	D Juarez, R Buono, SM Matulis, VA Gupta, M Duong, J Yudiono, M Paul, S Mallya, G Diep, P Hsin, A Lu, SM Suh, VM Dong, AW Roberts, JD Leverson, M Jalaluddin, Z Liu, OF Bueno, LH Boise, DA Fruman	08/12/2023
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy. The Journal of clinical investigation	MH Robinson, NY Villa, DL Jaye, AK Nooka, A Duffy, SS McCachren, J Manalo, JM Switchenko, S Barnes, S Potdar, MI Azeem, AA Horvat, VC Parihar, J Gong, Y Liang, GH Smith, VA Gupta, LH Boise, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, KM Dhodapkar, MV Dhodapkar	01/08/2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nature cancer	R de Matos Simoes, R Shirasaki, SL Downey-Kopyscinski, GM Matthews, BG Barwick, VA Gupta, D Dupéré-Richer, S Yamano, Y Hu, M Sheffer, E Dhimolea, O Dashevsky, S Gandolfi, K Ishiguro, RM Meyers, JG Bryan, NV Dharia, PJ Hengeveld, JB Brüggenthies, H Tang, AJ Aguirre, QL Sievers, BL Ebert, BJ Glassner, CJ Ott, JE Bradner, NP Kwiatkowski, D Auclair, J Levy, JJ Keats, RWJ Groen, NS Gray, AC Culhane, JM McFarland, JM Dempster, JD Licht, LH Boise, WC Hahn, F Vazquez, A Tsherniak, CS Mitsiades	01/05/2023
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal	KT Maples, KH Hall, NS Joseph, CC Hofmeister, V Gupta, MV Dhodapkar, JL Kaufman, AK Nooka, S Lonial	20/02/2023
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. Science advances	A Sharma, R Nair, A Achreja, A Mittal, P Gupta, K Balakrishnan, CL Edgar, O Animasahun, B Dwivedi, BG Barwick, VA Gupta, SM Matulis, M Bhasin, S Lonial, AK Nooka, AP Wiita, LH Boise, D Nagrath, M Shanmugam	30/09/2022
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma. Haematologica	R Nair, V Subramaniam, BG Barwick, VA Gupta, SM Matulis, S Lonial, LH Boise, AK Nooka, K Muthumalaiappan, M Shanmugam	01/09/2022
Venetoclax ex vivo functional profiling predicts improved progression-free survival. Blood cancer journal	VA Gupta, SM Matulis, BG Barwick, RD Bog, CW Shebelut, M Shanmugam, P Neri, NJ Bahlis, MV Dhodapkar, LT Heffner, CC Hofmeister, NS Joseph, S Lonial, JL Kaufman, DL Jaye, AK Nooka, LH Boise	04/08/2022
It takes T to tango: immunotherapy in MM. Blood	VA Gupta, MV Dhodapkar	03/03/2022
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. Leukemia	S Kunte, L Rybicki, A Viswabandya, R Tamari, A Bashey, A Keyzner, M Iqbal, MR Grunwald, B Dholaria, H Elmariah, M Ozga, A Singh, S Abedin, AE DeZern, RJ Jones, V Gupta, AT Gerds, T Jain	01/03/2022
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life. Transplantation and cellular therapy	NS Joseph, VA Gupta, S Wyman, M Graiser, JL Kaufman, D Almaula, J Andrews, C Hofmeister, M Dhodapkar, LT Heffner, S Lonial, AK Nooka	01/02/2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood	CR Funk, S Wang, KZ Chen, A Waller, A Sharma, CL Edgar, VA Gupta, S Chandrakasan, JT Zoine, A Fedanov, SS Raikar, JL Koff, CR Flowers, S Coma, JA Pachter, S Ravindranathan, HT Spencer, M Shanmugam, EK Waller	27/01/2022
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia. Blood cancer discovery	A Kaushal, AK Nooka, AR Carr, KE Pendleton, BG Barwick, J Manalo, SS McCachren, VA Gupta, NS Joseph, CC Hofmeister, JL Kaufman, LT Heffner, SM Ansell, LH Boise, S Lonial, KM Dhodapkar, MV Dhodapkar	01/11/2021
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood	VA Gupta, BG Barwick, SM Matulis, R Shirasaki, DL Jaye, JJ Keats, B Oberlton, NS Joseph, CC Hofmeister, LT Heffner, MV Dhodapkar, AK Nooka, S Lonial, CS Mitsiades, JL Kaufman, LH Boise	01/07/2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research	BG Barwick, VA Gupta, SM Matulis, JC Patton, DR Powell, Y Gu, DL Jaye, KN Conneely, YC Lin, CC Hofmeister, AK Nooka, JJ Keats, S Lonial, PM Vertino, LH Boise	01/06/2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo. Molecular therapy oncolytics	J Ghose, A Dona, M Murtadha, EG Gunes, E Caserta, JY Yoo, L Russell, AC Jaime-Ramirez, BG Barwick, VA Gupta, JF Sanchez, DW Sborov, ST Rosen, A Krishnan, LH Boise, B Kaur, CC Hofmeister, F Pichiorri	26/03/2021
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience. American journal of hematology	KT Maples, AK Nooka, V Gupta, NS Joseph, LT Heffner, C Hofmeister, M Dhodapkar, SM Matulis, S Lonial, LH Boise, JL Kaufman	01/03/2021
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma. Blood and lymphatic cancer : targets and therapy	VA Gupta, J Ackley, JL Kaufman, LH Boise	01/01/2021
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma. Blood cancer journal	Y Gu, BG Barwick, M Shanmugam, CC Hofmeister, J Kaufman, A Nooka, V Gupta, M Dhodapkar, LH Boise, S Lonial	14/12/2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	NS Joseph, JL Kaufman, MV Dhodapkar, CC Hofmeister, DK Almaula, LT Heffner, VA Gupta, LH Boise, S Lonial, AK Nooka	10/06/2020
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nature communications	R Bajpai, A Sharma, A Achreja, CL Edgar, C Wei, AA Siddiqa, VA Gupta, SM Matulis, SK McBrayer, A Mittal, M Rupji, BG Barwick, S Lonial, AK Nooka, LH Boise, D Nagrath, M Shanmugam	06/03/2020
Approaches to Treating Multiple Myeloma, Now and Moving Forward. JCO oncology practice	VA Gupta, NS Joseph, AK Nooka	01/01/2020
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood cancer journal	TM Schmidt, BG Barwick, N Joseph, LT Heffner, CC Hofmeister, L Bernal, MV Dhodapkar, VA Gupta, DL Jaye, J Wu, S Goyal, Z Chen, LH Boise, S Lonial, AK Nooka, JL Kaufman	25/11/2019
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients. Cancer	AK Nooka, NS Joseph, JL Kaufman, LT Heffner, VA Gupta, C Gleason, LH Boise, S Lonial	01/09/2019
Daratumumab in multiple myeloma. Cancer	AK Nooka, JL Kaufman, CC Hofmeister, NS Joseph, TL Heffner, VA Gupta, HC Sullivan, AS Neish, MV Dhodapkar, S Lonial	15/07/2019
Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma. Leukemia	SM Matulis, VA Gupta, P Neri, NJ Bahlis, P Maciag, JD Leverson, LT Heffner, S Lonial, AK Nooka, JL Kaufman, LH Boise	01/05/2019
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis. Nature communications	BG Barwick, P Neri, NJ Bahlis, AK Nooka, MV Dhodapkar, DL Jaye, CC Hofmeister, JL Kaufman, VA Gupta, D Auclair, JJ Keats, S Lonial, PM Vertino, LH Boise	23/04/2019
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	V Gupta, HE Kosiorek, A Mead, RB Klisovic, JP Galvin, D Berenzon, A Yacoub, A Viswabandya, RA Mesa, J Goldberg, L Price, ME Salama, RS Weinberg, R Rampal, N Farnoud, AC Dueck, JO Mascarenhas, R Hoffman	01/02/2019
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents. Cancer	R Mina, NS Joseph, JL Kaufman, VA Gupta, LT Heffner, CC Hofmeister, LH Boise, MV Dhodapkar, C Gleason, AK Nooka, S Lonial	01/02/2019
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma. Frontiers in immunology	BG Barwick, VA Gupta, PM Vertino, LH Boise	01/01/2019
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial. The Lancet. Haematology	CN Harrison, AM Vannucchi, U Platzbecker, F Cervantes, V Gupta, D Lavie, F Passamonti, EF Winton, H Dong, J Kawashima, JD Maltzman, JJ Kiladjian, S Verstovsek	01/02/2018
Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma. Blood	VA Gupta, SM Matulis, JE Conage-Pough, AK Nooka, JL Kaufman, S Lonial, LH Boise	06/04/2017
Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma. Cancer biology & therapy	KG Ponder, SM Matulis, S Hitosugi, VA Gupta, C Sharp, F Burrows, AK Nooka, JL Kaufman, S Lonial, LH Boise	02/07/2016
Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax. Leukemia	SM Matulis, VA Gupta, AK Nooka, HV Hollen, JL Kaufman, S Lonial, LH Boise	01/05/2016

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	20/03/2024	Dr. Gupta is very attentive, listens to all concerns and updates. Answers all questions and explains treatment progress
One star One star One star One star One star	20/03/2024	Dr. Gupta is an excellent lister and communicator.
One star One star One star One star One half star	04/03/2024	Dr. Gupta is a very good, and caring Doctor.
One star One star One star One star One star	28/02/2024	Great service
One star One star One star One star One star	22/02/2024	Always listens, always takes time to throughly answer questions
One star One star One star One star One star	24/01/2024	Dr. Gupta always listens, carefully considers my questions and relays a well thought out response.
One star One star One star One star One star	17/01/2024	Best doctor I have ever had in my life wished he could be my primary care doc
One star One star One star One star One star	30/12/2023	Dr. Gupta exceeds all expectations; he always answers questions, listens and offers sound advise.
One star One star One star One star One star	08/12/2023	Dr Gupta was thorough and reviewed the plan for continued treatment
One star One star One star One star One star	08/11/2023	Dr. Gupta always takes time to listen and answer all questions and concerns
One star One star One star One star One star	25/10/2023	The visit when well
One star One star One star One star One star	14/10/2023	Dr Gupta was excellent
One star One star One star One star One star	07/09/2023	Great team
One star One star One star One star One star	30/08/2023	Good
One star One star One star One star One star	16/08/2023	I was care for very well like if they really know me
One star One star One star One star One star	09/08/2023	Dr. Gupta always listens, always answers questions and genuinely seems interested.
One star One star One star One star One star	07/06/2023	Dr Gupta is very thorough , very professional, and personable. He is patient, listens well and explains everything
One star One star One star One star One star	10/05/2023	Dr. Gupta goes above and beyond, he always answers our questions, always treats each question with respect and we never feel rushed.
One star One star One star One star One star	05/04/2023	Dr. Gupta always takes time to answer all our questions, explains the test results and we never feel rushed.
One star One star One star One star One star	30/12/2022	Dr. Gupta is very knowledgeable, listens to my questions and throughly answers. If I do not understand his answer he will explain patiently until I do understand. He is never in a rush to get us out of the office; Dr. Gupta wants us comfortable with the treatments and procedures.
One star One star One star One star One star	30/11/2022	Attentive to my questions and answered them in understandable terms.